The Best Science, the Best People

It’s our primary investment.

Because the best science
demands the best people.

Meet Our Global Colleagues.

Explore the benefit program
and company perks.

See how your work will
change patiens lives

Because the best science
demands the best people.

Meet our Global Colleagues.

Explore our benefit program
and company perks.

See how your work will
change patients’ lives.

Where to begin?

Submit your resume today.

Twitter

Health centers are the backbone of our communities, providing care and support for everyone in need. That is why during #NationalHealthCenterWeek, we recognize and applaud health centers for their ongoing efforts to help keep us going strong. #HealthCenterWeek #HealthCenters

Keep up with the latest industry updates in #bioanalysis with the BioAgilytix #newsletter. Subscribe today >> https://bit.ly/3y1soYJ

Want to know what is new compared to the current FDA and EMEA guidelines Looking to explore that impact on your organization? Join #BioAgilytix in collaboration with @medicon_valley, on Aug. 16th, 2022 for a discussion on the new ICH m10 guidelines. https://bit.ly/3A3VHMC

Can advanced modalities be leveraged for extensive use for the purpose of drug quantitation? Listen to @JMcNally_BAL, Amanda L. Hays, PhD & Thomas J. Schneider, PhD share their thoughts on PK assessment for advanced modalities in this on-demand #webinar: https://bit.ly/3bDyZkA

Christian Braithwaite, Manager II, is among the authors who contributed to a pivotal paper in drug development that demonstrates a different way of measuring the magnitude of #ADA using signal to noise versus titer. Published by @AAPSComms: https://bit.ly/3PT35zE

Load More

Facebook

Cover for BioAgilytix
877
BioAgilytix

BioAgilytix

BioAgilytix is a leading global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development.

14 hours ago

BioAgilytix
Health centers are the backbone of our communities, providing care and support for those in need.During #NationalHealthCenterWeek, we applaud health centers for their ongoing efforts to help keep us going strong.#HealthCenterWeek #HealthCenters ... See MoreSee Less
View on Facebook

4 days ago

BioAgilytix
Keep up with the latest industry updates in #bioanalysis with the BioAgilytix #newsletter. Subscribe today >> bit.ly/3y1soYJ ... See MoreSee Less
View on Facebook

5 days ago

BioAgilytix
Planning to be in Copenhagen on August 16th? If so, please join #BioAgilytix in collaboration with the Medicon Valley Alliance for breakfast and a discussion on the new ICH M10 guidelines.Explore the new guidelines on the bioanalytical landscape with one of the Members of the Expert Working Group for ICH M10 Marianne Scheel Fjording, MSc, Ph.D., Scientific Officer Executive Director, BioAgilytix.Sign up >> bit.ly/3A3VHMC ... See MoreSee Less
View on Facebook

5 days ago

BioAgilytix
Christian Braithwaite, Manager II at our Boston lab, is among the authors who contributed to a pivotal paper in drug development that demonstrates a different way of measuring the magnitude of #ada using signal to noise versus titer. Click here to read the full paper that was recently published in the July 2022 volume of the American Association of Pharmaceutical Scientists (AAPS) Journal: bit.ly/3PT35zE #thoughtleadership #ADAAssay #research #science #AAPS #biologyagilityanalytics ... See MoreSee Less
View on Facebook

5 days ago

BioAgilytix
Can advanced modalities be leveraged for extensive use for the purpose of drug quantitation?Listen to Jim McNally, Ph.D., Amanda L. Hays, Ph.D., and Thomas J. Schneider, Ph.D. share their thoughts on PK assessment for advanced modalities in this on-demand webinar: bit.ly/3bDyZkA#webinar #pkassessment #flowcytometry #BioAgilytix ... See MoreSee Less
View on Facebook